PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350322
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1350322
The global automated CPR devices market is estimated to be valued at US$ 127.6 million in 2023 and is expected to exhibit a CAGR of 11.5% during the forecast period (2023-2030).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 127.7 Mn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 11.50% | 2030 Value Projection: | US$ 273.9 Mn |
Automated CPR Devices are used in Emergency Medical Services (EMS), hospitals, ambulances, coronary and intensive care units, cardiac catheterization labs, air medevac units, and Emergency Medical Technician (EMT) rescue units. Increasing adoption of automated CPR by emergency services is expected to propel growth of the global automated CPR devices market over the forecast period. Moreover, initiatives of government and private organizations to boost adoption of automated CPR devices, along with the increasing prevalence of CVD are expected to assist the growth of the market during the forecast period. Cardiopulmonary resuscitation (CPR) combines rescue breathing (mouth-to-mouth) and chest compressions to temporarily pump enough blood to the brain until specialized treatment is available. The high prevalence of cardiovascular disease (CVD) and increasing geriatric population are expected to fuel the growth of the global automated CPR devices market over the forecast period. Cardiopulmonary resuscitation (CPR) is an emergency and lifesaving technique consists of chest compression and artificial ventilation. CPR is performed to maintain the blood flow and oxygenation to brain in case of cardiac arrest. CPR main function is to maintain partial flow of oxygenated blood to brain and heart. The main purpose is to delay tissue death to achieve successful resuscitation and protecting brain from permanent damage.
Increasing prevalence of cardiovascular disease (CVD) and increasing number of geriatric population are expected to propel the growth of global automated CPR devices market over the forecast period. For instance, on January 25, 2023, according to the American Heart Association and Stroke Statistics 2023 update, in 2020 in the U.S., coronary heart disease (CHD) was the leading cause (41.2%) of deaths attributable to CVD in the U.S., followed by stroke (17.3%), other CVD (16.8%), high blood pressure (12.9%), heart failure (9.2%), and diseases of the arteries (2.6%).